Common heart drug may up sudden cardiac arrest risk

Image
IANS London
Last Updated : Mar 17 2019 | 8:11 PM IST

A drug commonly used to treat high blood pressure and chest pain could be associated with an increased risk of sudden cardiac arrest, according to a study.

Doctors from the Academic Medical Center in Amsterdam, the Netherlands, examined over 60,000 people to determine whether nifedipine and amlodipine or dihydropyridines -- widely used for high blood pressure and angina -- were linked with out-of-hospital cardiac arrest.

The results, presented at the annual congress of European Heart Rhythm Association 2019 in Lisbon, showed that high-dose (60 mg/day) nifedipine was significantly associated with an increased risk of out-of-hospital cardiac arrest with any dose of amlodipine.

There was no risk associated with amlodipine.

"Nifedipine and amlodipine are often used by many cardiologists and other physicians, and the choice often depends on the prescriber's preference and personal experience," said Hanno Tan, cardiologist at the Academic Medical Center.

The findings are surprising given that both the drugs have been in use for many years.

However, the researchers urged caution when interpreting the results.

"The findings need to be replicated in other studies before action could be taken by doctors or patients," Tan said.

In sudden cardiac arrest, the heart stops pumping after a cardiac arrhythmia (ventricular fibrillation/tachycardia). This can be lethal if untreated.

--IANS

rt/arm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 17 2019 | 7:28 PM IST

Next Story